Methamphetamine continues to be labelled from the U.S. Drug Enforcement Administration as a Program II stimulant, that makes it authorized being only through a non-refillable prescription. Medically, it can be indicated with the treatment of awareness deficit hyperactivity problem (ADHD) and as a short-phrase period concern for bodyweight reduction